26th September 2025
Krishgen Biosystems was honoured with the Best Research Poster Award at PCG 2025 for its study on the KRIBIOLISA™ Tirzepatide (Mounjaro®) ELISA.
The poster highlighted the development and validation of a highly sensitive, specific, and reproducible assay for quantifying Tirzepatide in human serum and plasma. Demonstrating strong linearity, precision, and low inter-matrix variability, the study showcased Krishgen’s commitment to advancing reliable immunoassay tools for pharmacokinetic and biosimilar research. This recognition underscores Krishgen’s growing leadership in peptide and metabolic biomarker assay innovation.
